Related Experiment Video
Updated: Apr 4, 2026

08:01
A Web Tool for Generating High Quality Machine-readable Biological Pathways
Published on: February 8, 2017
18.7K
ExposoGraph: An Interactive Platform for Carcinogen Bioactivation and Detoxification Pathway Visualization
Julhash U Kazi1,2,3,4, Kenneth J Pienta5,4
1Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, 22363, Sweden.
Biorxiv : the Preprint Server for Biology
|April 3, 2026
Summary
ExposoGraph integrates carcinogen exposure, metabolism, and genetic data into an interactive knowledge graph. This tool aids in understanding gene-environment interactions for cancer risk assessment.
Area of Science:
- Bioinformatics
- Genomics
- Toxicology
Background:
- Limited platforms integrate carcinogenic exposures, metabolic activation/detoxification, DNA damage, and genetic annotations.
- This gap hinders systematic evaluation of gene-environment interactions in cancer risk assessment.
Purpose of the Study:
- To develop ExposoGraph, an interactive knowledge-graph platform for carcinogen metabolism and DNA damage pathways.
- To unify data from IARC, KEGG, PharmVar, CPIC, and CTD for a comprehensive view of gene-environment interactions.
Main Methods:
- Developed a knowledge graph with 96 nodes (Carcinogens, Enzymes, Metabolites, DNA Adducts, Pathways) and 102 edges (activates, detoxifies, transports, forms adduct, repairs).
- Integrated curated data and annotations from multiple reputable resources.
- Implemented interactive exploration features including filtering and detailed views with provenance.
Main Results:
- The graph captures metabolic activation/detoxification for 9 carcinogen classes and 15 index carcinogens.
- Represents 36 enzymes involved in Phase I, II, III metabolism, and DNA repair.
- Demonstrated cross-pathway connectivity, linking androgen metabolism to estrogen quinone formation and DNA adducts via CYP19A1.
Conclusions:
- ExposoGraph offers an integrated, interactive framework linking exposures to metabolic fates and genetic factors.
- Supports hypothesis generation for gene-environment interaction studies and potential individualized risk modeling.
- Currently a research framework, not a clinically validated risk-assessment tool.
Keywords:
D3 HTMLcarcinogenesischemical carcinogenesisgene-environment interactioninteractive platformknowledge graphmetabolic activationnetwork visualizationpharmacogenomicsMore Related Videos
Related Concept Videos
Bioactivation and Tissue Toxicity
111
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
111
Mutagenicity and Carcinogenicity
2.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
1.2K
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
1.2K
Toxic Reactions: Overview
3.9K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
3.9K

